FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely obstetrics, and may be used for treating moderate and severe intrahepatic cholestasis of pregnancy. For this purpose with underlying daily infusions of Heptral 800 mg, there are applied carbohemasorption courses 2 procedures a week for 60-90 minutes starting with the 24-26th week of pregnancy to a period of viable foetus.
EFFECT: method provides preventing foetoplacental deficiency, foetal growth retardation syndrome, preterm labour due to effective reduction of intrahepatic cholestasis.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING AND MANAGING PREGNANT WOMEN WITH DRUG-INDUCED HEPATITIS | 2013 |
|
RU2537120C2 |
| METHOD OF DIAGNOSING LINGERING VERSION OF JAUNDICE CLINICAL COURSE IN NEWBORNS AND CHILDREN OF FIRST YEAR OF LIFE | 2009 |
|
RU2440579C2 |
| METHOD OF TREATING CHILDREN WITH MANIFESTATION OF LINGERING JAUNDICE IN NEONATAL PERIOD | 2009 |
|
RU2432938C2 |
| HEPATOPROTECTOR PREPARATION FOR PROPHYLAXIS AND CORRECTION OF TOXIC HEPATIC LESIONS | 2001 |
|
RU2189817C1 |
| METHOD OF SCREENING HEPATIC DISORDERS, AND SYSTEM FOR IMPLEMENTING METHOD | 2013 |
|
RU2523661C1 |
| METHOD FOR DIAGNOSTICS OF VIRAL, ALCOHOLIC, VIRAL AND ALCOHOLIC ETIOLOGY OF DIFFUSED LIVER DISEASES BOTH WITHOUT PROGRESSION AND WITH PROGRESSION | 2022 |
|
RU2792320C1 |
| METHOD FOR EXAMINATION OF CHILDREN WITH SUSPECTED PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC) | 2016 |
|
RU2627615C1 |
| AGENT WITH PANCREAS AND HEPATOPROTECTIVE ACTIVITY FOR PARENTERAL ADMINISTRATION | 2017 |
|
RU2662324C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2386134C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR LIVER DISEASES OF VARIOUS AETIOLOGIES ACCOMPANIED WITH INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2386969C2 |
